Anuh Pharma Ltd.

Financial

	Anuh Pharma	Wanbury	Shivalik Rasayan
Operational Metrics
Pharmaceutical Sector
R&D as a % of Total Sales	0.0	n/a	n/a
Financials
5 yr Average ROE	15.87 %	-30.56 %	7.33 %
5yr average Equity Multiplier	1.62	-3.1	1.84
5yr Average Asset Turnover Ratio	1.35	1.51	0.47
5yr Avg Net Profit Margin	7.23 %	7.58 %	8.37 %
Price to Book	2.71	13.99	1.53
P/E	19.18	19.28	54.58
5yr Avg Cash Conversion Cycle	42.81 Days	-119.82 Days	79.22 Days
Inventory Days	50.87 Days	20.62 Days	63.09 Days
Days Receivable	111.12 Days	49.78 Days	114.67 Days
Days Payable	117.6 Days	205.91 Days	157.87 Days
5yr Average Interest Coverage Ratio	48.66	2.36	10.93
5yr Avg ROCE	21.17 %	-51.74 %	9.58 %
5yr Avg Operating Profit Margin	10.21 %	4.22 %	18.09 %
5 yr average Debt to Equity	0.02	-0.61	0.16
5yr CAGR Net Profit	10.73 %	-2.79 %	-1.91 %
5yr Average Return on Assets	9.84 %	11.1 %	3.97 %
Shareholdings
Promoter Holding	69.92 %	39.63 %	47.37 %
Share Pledged by Promoters	0.0	76.74 %	0.0
Change in Promoter Holding (3 Yrs)	-0.67 %	-0.22 %	-2.95 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Anuh Pharma	Wanbury	Shivalik Rasayan
Product Wise Break-Up	Product Wise Break-Up Bulk drug and Chemicals 100.0 API`s & Formulation 0 ACTIVE PHARMA INGREDIENT 0 Pharma 0 Agrochemicals 0	Product Wise Break-Up Pharma 0 Bulk drug and Chemicals 0 ACTIVE PHARMA INGREDIENT 0 Agrochemicals 0 API`s & Formulation 0 Others 100	Product Wise Break-Up Pharmaceutical 43.36 Bulk drug and Chemicals 0 ACTIVE PHARMA INGREDIENT 0.87 Agro Chemicals 55.77 API`s & Formulation 0
Location Wise Break-Up	Location Wise Break-Up India 45.02 Rest of the World 0 Others 54.98	Location Wise Break-Up India 38.09 Rest of the World 0 Others 61.91	-
Brand Wise Break-Up	Brand Wise Break-Up Erythromycin 33.38 Cortico Steroids 15.41 Higher Macrolides 14.5 Sulphadoxine 13.6 Pyrazinamide 5.74 Chloramhenicol 4.98 Gliclazide 4.23 Ambroxol HCL 3.02 Others 5.14	-	-